10x Genomics (TXG) Capital Expenditures Growth (1y) (2019 - 2026)

10x Genomics (TXG) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Veeva Systems 31.58 Bn 24.27 Bn 662.02 Mn -70.37%
2 BrightSpring Health Services 14.80 Bn 13.90 Bn 482.22 Mn 22.19%
3 Healthequity 8.18 Bn 7.91 Bn 256.31 Mn -0.79%
4 10x Genomics 5.97 Bn 5.43 Bn 106.18 Mn -93.77%
5 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn -
6 MiniMed 4.49 Bn 4.19 Bn 480.00 Mn -1.75%
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn 27,269.64%
8 Doximity 3.90 Bn 3.15 Bn 125.97 Mn -32.48%
9 Privia Health 3.19 Bn 2.77 Bn - -255.64%
10 Omnicell 1.88 Bn 1.64 Bn 140.36 Mn 21.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 -93.77%
Dec 31, 2025 169.66%
Sep 30, 2025 -104.27%
Jun 30, 2025 -140.94%
Mar 31, 2025 -0.32%
Dec 31, 2024 -118.22%
Sep 30, 2024 160.60%
Jun 30, 2024 -18.26%
Mar 31, 2024 -58.35%
Dec 31, 2023 15.02%
Sep 30, 2023 -117.55%
Jun 30, 2023 -82.52%
Mar 31, 2023 -83.80%
Dec 31, 2022 43.87%
Sep 30, 2022 -44.71%
Jun 30, 2022 186.83%
Mar 31, 2022 -27.61%
Dec 31, 2021 22.84%
Sep 30, 2021 463.94%
Jun 30, 2021 -8,681.23%